These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24456036)

  • 21. Aortic stiffness, inflammation, denutrition and type 2 diabetes in the elderly.
    Blacher J; Protogerou AD; Henry O; Czernichow S; Iaria P; Zhang Y; Agnoletti D; Safar ME
    Diabetes Metab; 2012 Feb; 38(1):68-75. PubMed ID: 22030242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulse pressure and cardiovascular autonomic neuropathy according to duration of type 1 diabetes.
    Philips JC; Marchand M; Scheen AJ
    Diabetes Metab Res Rev; 2009 Jul; 25(5):442-51. PubMed ID: 19437445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between markers of endothelial dysfunction and early signs of renal dysfunction in pediatric obesity and type 1 diabetes.
    Marcovecchio ML; de Giorgis T; Di Giovanni I; Chiavaroli V; Chiarelli F; Mohn A
    Pediatr Diabetes; 2017 Jun; 18(4):283-289. PubMed ID: 27246625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High normal albuminuria is independently associated with aortic stiffness in patients with Type 2 diabetes.
    Liu JJ; Tavintharan S; Yeoh LY; Sum CF; Ng XW; Pek SL; Lee SB; Tang WE; Lim SC;
    Diabet Med; 2014 Oct; 31(10):1199-204. PubMed ID: 24702136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-grade inflammation and arterial wave reflection in patients with chronic fatigue syndrome.
    Spence VA; Kennedy G; Belch JJ; Hill A; Khan F
    Clin Sci (Lond); 2008 Apr; 114(8):561-6. PubMed ID: 18031285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arterial stiffness and endothelial dysfunction independently and synergistically predict cardiovascular and renal outcome in patients with type 1 diabetes.
    Theilade S; Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
    Diabet Med; 2012 Aug; 29(8):990-4. PubMed ID: 22414297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes.
    Theilade S; Lyngbaek S; Hansen TW; Eugen-Olsen J; Fenger M; Rossing P; Jeppesen JL
    J Intern Med; 2015 Mar; 277(3):362-371. PubMed ID: 24830873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies.
    Peeters SA; Engelen L; Buijs J; Chaturvedi N; Fuller JH; Jorsal A; Parving HH; Tarnow L; Theilade S; Rossing P; Schalkwijk CG; Stehouwer CDA
    Cardiovasc Diabetol; 2017 Oct; 16(1):139. PubMed ID: 29070037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble adhesion molecules and C-reactive protein in the progression of silent cerebral infarction in patients with type 2 diabetes mellitus.
    Kawamura T; Umemura T; Kanai A; Nagashima M; Nakamura N; Uno T; Nakayama M; Sano T; Hamada Y; Nakamura J; Hotta N
    Metabolism; 2006 Apr; 55(4):461-6. PubMed ID: 16546476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.
    Schaumberg DA; Glynn RJ; Jenkins AJ; Lyons TJ; Rifai N; Manson JE; Ridker PM; Nathan DM
    Circulation; 2005 May; 111(19):2446-53. PubMed ID: 15867184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between future events of brain infarction and soluble levels of intercellular adhesion molecule-1 and C-reactive protein in patients with type 2 diabetes mellitus.
    Kanai A; Kawamura T; Umemura T; Nagashima M; Nakamura N; Nakayama M; Sano T; Nakashima E; Hamada Y; Nakamura J; Hotta N
    Diabetes Res Clin Pract; 2008 Nov; 82(2):157-64. PubMed ID: 18692933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arterial stiffness in adolescents and young adults with and without type 1 diabetes: the SEARCH CVD study.
    Shah AS; Wadwa RP; Dabelea D; Hamman RF; D'Agostino R; Marcovina S; Daniels SR; Dolan LM; Fino NF; Urbina EM
    Pediatr Diabetes; 2015 Aug; 16(5):367-74. PubMed ID: 25912292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes.
    Glowinska B; Urban M; Peczynska J; Florys B
    Metabolism; 2005 Aug; 54(8):1020-6. PubMed ID: 16092051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etanercept improves inflammation-associated arterial stiffness in rheumatoid arthritis.
    Galarraga B; Khan F; Kumar P; Pullar T; Belch JJ
    Rheumatology (Oxford); 2009 Nov; 48(11):1418-23. PubMed ID: 19734293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Candesartan effect on inflammation in hypertension.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Hypertens Res; 2010 Mar; 33(3):209-13. PubMed ID: 20075928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrinogen and d-dimer in contrasting relation with measures of wave reflection and arterial stiffness.
    Wykretowicz J; Guzik P; Krauze T; Marciniak R; Komarnicki M; Piskorski J; Wysocki H; Wykretowicz A
    Scand J Clin Lab Invest; 2012 Dec; 72(8):629-34. PubMed ID: 23020230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HbA1c but not diabetes duration predicts increased arterial stiffness in adolescents with poorly controlled type 1 diabetes.
    Obermannova B; Petruzelkova L; Sulakova T; Sumnik Z
    Pediatr Diabetes; 2017 Jun; 18(4):304-310. PubMed ID: 27075550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
    Ridker PM; Hennekens CH; Buring JE; Rifai N
    N Engl J Med; 2000 Mar; 342(12):836-43. PubMed ID: 10733371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
    Koenig W
    Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes.
    Ha CY; Kim JY; Paik JK; Kim OY; Paik YH; Lee EJ; Lee JH
    Clin Endocrinol (Oxf); 2012 May; 76(5):674-82. PubMed ID: 21958081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.